| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.61▲ | 7.68▼ | 7.69▼ | 8.10▼ | 8.38▼ |
| MA10 | 7.63▼ | 7.72▼ | 7.85▼ | 8.26▼ | 8.52▼ |
| MA20 | 7.66▼ | 7.87▼ | 8.00▼ | 8.49▼ | 8.87▼ |
| MA50 | 7.71▼ | 8.06▼ | 8.22▼ | 8.58▼ | 6.73▲ |
| MA100 | 7.84▼ | 8.25▼ | 8.40▼ | 8.68▼ | N/A |
| MA200 | 8.00▼ | 8.41▼ | 8.72▼ | 7.15▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.018▼ | -0.042▼ | -0.079▼ | -0.263▼ |
| RSI | 37.625▼ | 20.836▼ | 24.617▼ | 33.175▼ | 47.209▼ |
| STOCH | 26.641 | 11.044▼ | 4.630▼ | 18.314▼ | 25.729 |
| WILL %R | -62.500 | -92.241▼ | -93.836▼ | -96.734▼ | -98.565▼ |
| CCI | -32.193 | -117.139▼ | -106.781▼ | -204.872▼ | -123.719▼ |
|
Sunday, September 06, 2026 04:48 PM
Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has appointed experienced financial executive Brent Moen as chief financial officer, effective September 12, 2026 AEST. Moen brings more than 25 ...
|
|
Saturday, June 06, 2026 05:00 PM
1 Day AVR -0.25% DJIA -0.36% Russell 2K 0.51% Health Care/Life Sciences 1.12% ...
|
|
Thursday, April 23, 2026 05:00 AM
Anteris Technologies is developing DurAVR, a differentiated biomimetic TAVR device with encouraging early clinical data in over 130 patients. AVR’s PARADIGM pivotal trial is the central catalyst. This ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/09/26 | 8.03 | 8.035 | 7.57 | 7.62 | 866,837 |
| 22/09/26 | 8.27 | 8.32 | 8.055 | 8.13 | 842,610 |
| 21/09/26 | 8.20 | 8.24 | 7.99 | 8.15 | 739,357 |
| 18/09/26 | 8.40 | 8.57 | 8.12 | 8.16 | 1,808,956 |
| 17/09/26 | 8.50 | 8.60 | 8.35 | 8.42 | 444,982 |
| 16/09/26 | 8.36 | 8.47 | 8.26 | 8.37 | 968,154 |
| 15/09/26 | 8.68 | 8.71 | 8.30 | 8.34 | 583,464 |
| 14/09/26 | 8.32 | 8.73 | 8.255 | 8.72 | 551,837 |
| 11/09/26 | 8.41 | 8.565 | 8.10 | 8.35 | 640,344 |
| 10/09/26 | 8.35 | 8.45 | 8.2301 | 8.30 | 842,347 |
|
|
||||
|
|
||||
|
|